JP2005187427A5 - - Google Patents

Download PDF

Info

Publication number
JP2005187427A5
JP2005187427A5 JP2003433754A JP2003433754A JP2005187427A5 JP 2005187427 A5 JP2005187427 A5 JP 2005187427A5 JP 2003433754 A JP2003433754 A JP 2003433754A JP 2003433754 A JP2003433754 A JP 2003433754A JP 2005187427 A5 JP2005187427 A5 JP 2005187427A5
Authority
JP
Japan
Prior art keywords
glutamic acid
activity
lymphocytes
polygamma glutamic
proliferation activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003433754A
Other languages
Japanese (ja)
Other versions
JP2005187427A (en
JP4860109B2 (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2003433754A priority Critical patent/JP4860109B2/en
Priority claimed from JP2003433754A external-priority patent/JP4860109B2/en
Publication of JP2005187427A publication Critical patent/JP2005187427A/en
Publication of JP2005187427A5 publication Critical patent/JP2005187427A5/ja
Application granted granted Critical
Publication of JP4860109B2 publication Critical patent/JP4860109B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Claims (7)

有効量のポリガンマグルタミン酸と薬学的に許容される担体を含むマクロファージの活性、Ｔリンパ球およびＢリンパ球の増殖活性誘導用組成物。 A composition for inducing macrophage activity, T lymphocyte proliferation activity, and B lymphocyte proliferation activity comprising an effective amount of polygamma glutamic acid and a pharmaceutically acceptable carrier. ポリガンマグルタミン酸は、１ｋＤａ〜１５０００ｋＤａの分子量を有することを特徴とする請求項１に記載のマクロファージの活性、Ｔリンパ球およびＢリンパ球の増殖活性誘導用組成物。 2. The composition for inducing macrophage activity, T lymphocyte and B lymphocyte proliferation activity according to claim 1, wherein the polygamma glutamic acid has a molecular weight of 1 kDa to 15000 kDa. ポリガンマグルタミン酸を含有するワクチン用アジュバント。   An adjuvant for vaccines containing polygamma glutamic acid. ポリガンマグルタミン酸は、１ｋＤａ〜１５０００ｋＤａの分子量を有することを特徴とする請求項３に記載のワクチン用アジュバント。   The adjuvant for vaccines according to claim 3, wherein polygamma glutamic acid has a molecular weight of 1 kDa to 15000 kDa. ポリガンマグルタミン酸および食品学的に許容される添加剤を含み、マクロファージの活性、Ｔリンパ球およびＢリンパ球の増殖活性誘導効果を有する機能性食品。 A functional food containing polygamma glutamic acid and a food-acceptable additive, and having an effect of inducing macrophage activity, proliferation activity of T lymphocytes and B lymphocytes . 有効量のポリガンマグルタミン酸を含むことを特徴とするマクロファージの活性、Ｔリンパ球およびＢリンパ球の増殖活性誘導効果を有する家畜用飼料組成物。 A livestock feed composition having an effect of inducing proliferation activity of macrophages and proliferation activity of T lymphocytes and B lymphocytes , comprising an effective amount of polygamma glutamic acid. ポリガンマグルタミン酸を、人間を除いて免疫増強が必要な動物に有効量を投与することを特徴とする動物のマクロファージの活性、Ｔリンパ球およびＢリンパ球の増殖活性誘導方法。 A method for inducing the activity of macrophages in animals, the proliferation activity of T lymphocytes and B lymphocytes, comprising administering an effective amount of polygamma glutamic acid to animals that need immune enhancement except humans.
JP2003433754A 2003-12-26 2003-12-26 Composition for enhancing immunity comprising polygamma glutamic acid Expired - Lifetime JP4860109B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003433754A JP4860109B2 (en) 2003-12-26 2003-12-26 Composition for enhancing immunity comprising polygamma glutamic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003433754A JP4860109B2 (en) 2003-12-26 2003-12-26 Composition for enhancing immunity comprising polygamma glutamic acid

Publications (3)

Publication Number Publication Date
JP2005187427A JP2005187427A (en) 2005-07-14
JP2005187427A5 true JP2005187427A5 (en) 2009-04-02
JP4860109B2 JP4860109B2 (en) 2012-01-25

Family

ID=34791051

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003433754A Expired - Lifetime JP4860109B2 (en) 2003-12-26 2003-12-26 Composition for enhancing immunity comprising polygamma glutamic acid

Country Status (1)

Country Link
JP (1) JP4860109B2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100517114B1 (en) * 2005-02-25 2005-09-27 주식회사 바이오리더스 Composition for adjuvant containing poly-gamma-glutamic acid
US7785612B2 (en) 2005-04-20 2010-08-31 Taiho Pharmaceutical Co., Ltd. Polyamino acid for use as adjuvant
US20080206276A1 (en) 2005-07-08 2008-08-28 Michael Otto Targeting Poly-Gamma-Glutamic Acid to Treat Staphylococcus Epidermidis and Related Infections
US8524303B2 (en) * 2005-11-23 2013-09-03 The Coca-Cola Company High-potency sweetener composition with phytosterol and compositions sweetened therewith
KR101825138B1 (en) * 2016-10-11 2018-02-06 주식회사 삼양애니팜 Veterinary composition for inhibiting abnormal meat
KR102094182B1 (en) * 2018-06-28 2020-03-30 주식회사 알랙스탠드 water-soluble polyglutamic acid complex composition containing zinc

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6437251A (en) * 1987-08-03 1989-02-07 Takeda Chemical Industries Ltd Beverage and method for improving quality thereof
JP2844645B2 (en) * 1989-03-22 1999-01-06 味の素株式会社 Beverage agent
JPH0347087A (en) * 1989-03-23 1991-02-28 Ajinomoto Co Inc New gamma-polyglutamic acid, production thereof and drink agent containing the same
JPH0928309A (en) * 1995-05-12 1997-02-04 Ajinomoto Co Inc Feed containing poly-gamma-glutamic acid
GB9622159D0 (en) * 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
JP3838283B2 (en) * 1996-10-25 2006-10-25 味の素株式会社 Feed composition containing poly-γ-glutamic acid
JP4484014B2 (en) * 2002-03-07 2010-06-16 ヒガシマル醤油株式会社 Hyaluronidase inhibition, antiallergic activity and immunostimulatory substances

Similar Documents

Publication Publication Date Title
WO2006002976A3 (en) Canine osteoarthritis diet formulation
HUP0200075A2 (en) Antioxidant compositions and methods for companion animals
HK1110016A1 (en) A pharmaceutical composition for the treatment of pathologies caused by the general response of the immune system
WO2004080196A3 (en) Feed formulation for terrestrial and aquatic animals
IL199364A0 (en) Use of pyy for preparation of a medicament for modification of feeding behavior
JP2013516188A5 (en)
JP2005187427A5 (en)
RU2005135231A (en) METHOD FOR INCREASING PRODUCTIVITY OF CHICKEN BROILERS
CN203058055U (en) Chain-type suspended welfare toy for pigs
JP4534579B2 (en) Lysine-containing anti-obesity or anti-hyperlipidemic food, feed or supplement
RU2013154564A (en) METHODS AND COMPOSITIONS FOR STIMULATING GROWTH OF AN OIL-FREE BODY WEIGHT
JP2014505679A5 (en)
WO2019211836A8 (en) Compositions and methods for nourishing mammals
DK1282362T3 (en) Feeds that reduce the rate of feed intake in dogs
Thors et al. The effect of dietary fish oil on survival after infection with Klebsiella pneumoniae or Streptococcus pneumoniae
JP2011506479A5 (en)
JP2007516945A5 (en)
WO2004069177A3 (en) Methods for modulating an inflammatory response
TR200102651T2 (en) Carnitine-added diet to prevent sudden death syndrome
RU2013154562A (en) METHODS AND COMPOSITIONS FOR PRESERVING THE BEAUTY BODY WEIGHT IN THE PROCESS OF SLIMMING
RU2004117943A (en) METHOD FOR INCREASING THE LEVEL OF NATURAL RESISTANCE OF THE ORGANISM AND PRODUCTIVE QUALITIES OF YOUNG PIG IN THE CONDITIONS OF INCREASED DENSITY OF SOIL CONTAMINATION BY RADIOCESION
Kim et al. Effects of supplementation with transgenic Bacillus subtilis secreting chitinase on growth performance, nutrient digestibility, blood characteristics, and carcass traits in finishing pigs
RU2004109902A (en) HEALING FOOD FOR FISH
JP4911374B2 (en) Lysine-containing anti-obesity or anti-hyperlipidemic food, feed or supplement
JP2004256395A5 (en)